HiberCell has acquired genomics analytic services provider Genuity Science, which had previously been bought by WuXi AppTec before being spun off last year.
Genuity Science, a US-based genomics analytic services provider backed by pharmaceutical firm WuXi AppTec, has been acquired by cancer treatment developer HiberCell in an all-stock transaction worth an undisclosed amount.
The acquisition includes the Genuity Science business and its subsidiaries, Genuity Science (Iceland) and Genuity Science (Ireland). It also provides HiberCell with some $100m in cash and partnership agreements with pharmaceutical firms Ionis Pharmaceuticals and AbbVie.
The combined company is set to accelerate its clinical programmes and expand its pipeline…
